RIS Rx

risrx.com · Tampa, United States of America

RISRX is a healthcare technology company that provides software and services to support pharmacy benefit management, prescription cost optimization, and related analytics for employers, health plans, and other healthcare stakeholders. Its platform focuses on improving transparency and control over drug spend and pharmacy benefits through data-driven tools and advisory services.

  • IT Consulting & Implementation
  • Business Intelligence & Dashboards
Revenue
$4.0M
Employees
25
Founded
2019
Headquarters
Tampa, United States of America

What 6 Arbolus experts think of RIS Rx

NPS scores among customers range from 6 to 9, with a concentration in the 7–9 band, indicating lean-positive sentiment. Renewal intent shows uncertainty—67% of respondents are unsure, and only one respondent is firmly planning to renew. Stickiness is mixed: 67% of implementations are less than a year old or in pilot, while only 17% are at more than a year. The primary theme is high initial spend coupled with tentative renewal intent, reflecting caution possibly tied to new deployments and unproven long-term value.Overall Customer Sentiment: Neutral

Who reviewed RIS Rx

Total customers 6 4 current · 2 former
Reviews growth +1 in six months
Seniority of respondents
  • C-Suite 33% (2)
  • Director 67% (4)
Operations Generalist Director NPS 9 Undecided
Legal Leader Director NPS 6 Undecided
Operations Leader Director NPS 8 Will renew

Employer names and spend open once the report publishes.

Tell us when the RIS Rx report publishes.

We'll email you once the full customer report is ready, with employer names, spend and every written answer. No account needed.

Notify me

Sentiment

16 Net Promoter Score, from 6 scored reviews
  • Promoters 2
  • Passives 3
  • Detractors 1

Cumulative NPS by month

+0 over 3 months
  • Jan 8
  • Mar 8
  • Apr 8

Net Promoter Score across 1 reviews, accumulated up to each month. Category median 16 across 1 companies.

Written answers and themes publish with the full report.

Renewal intent

Plan to renew 20%
  • Will renew 1
  • Undecided 4
  • Not renewing 0

Plan to renew, by seniority

  • C-Suite 0% 2 answers
  • Director 33% 3 answers
  • 8/10 Average score from customers who will renew
  • 7.8/10 Average score from undecided customers

For people who use RIS Rx

Do you use RIS Rx at work?

Share your software review and get matched to paid projects. Arbolus pays you every time a client reads your review.

  • 6 customers of RIS Rx have already contributed
Share your experience

Takes a few minutes. Your identity stays anonymous.